|
US2020273161A1
|
|
Method, System and Computer Program for Computer-Assisted Evaluation of Biomarkers in a Tissue Sample
|
|
WO2018002155A1
|
|
Treatments of non-alcoholic steatohepatitis (nash)
|
|
WO2017140803A1
|
|
Modulators of tumor immune resistance for the treatment of cancer
|
|
WO2017140793A1
|
|
Modulators of ccr9 for treating tumor resistance to immune responses
|
|
EP3264322A1
|
|
Machine learning-based quantitative photoacoustic tomography (pat)
|
|
EP3225253A1
|
|
Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor
|
|
EP3216415A1
|
|
A system for navigated punction, biopsy or ablation comprising a needle-like instrument and a removable sensor carrier
|
|
EP3250928A1
|
|
Methods for a quantitative release of biotinylated peptides and proteins from streptavidin complexes
|
|
EP3193173A1
|
|
Serological autoantibodies as biomarker for colorectal cancer
|
|
EP3165153A1
|
|
System for fluorescence aided surgery
|
|
EP3147366A1
|
|
Death receptor based selection marker
|
|
EP3144321A1
|
|
Mammalian dickkopf 3 (dkk3) as urinary marker for renal interstitial fibrosis/tubular atrophy (if/ta) and progressive kidney failure
|
|
EP3126845A1
|
|
Mammalian dickkopf 3 (dkk3) as urinary marker for chronic kidney diseases
|
|
DE19819846A1
|
|
Multivalent antibody constructs
|
